Question 1

What specific benefits might I expect from this new treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the genetically modified cells?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

Question 5

What will happen if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my overall health be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases clinical trial (NCT02688686). Contact the study team or your healthcare provider for specific answers.

What this study is about